drugset / Trial / NCT01746680
Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis
NaSingle-groupOpen-labelTreatment
Summary
The aims of this study are to assess the efficacy and safety of tacrolimus in patients with active rheumatoid arthritis(RA). EULAR(European League Against Rheumatism) response at week 24 compared to baseline will be evaluated to assess the efficacy of Tacrolimus.
Timeline
- Start
- 2012-08
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 3 mg | Oral |
| Background | Methotrexate | Small molecule | 20 mg | — |